Analysis of the literature and our research showed that an imbalance of the intestinal microbiota is associated with many diseases. We present some of the mechanisms of disease. Using non-invasive, simple, affordable method of deter-mination of fecal calprotectin reveals the presence and progression of chronic non-specific inflammatory bowel disease, and can be widely used in clinical practice
intestinal microflora, microbiota, fecal calprotectin, Crohn’s disease, ulcerative colitis, diagnosis of nonspecific inflammation
1. BlaserMJ, FalkowS (2014). Disappearing microbi-ota [Ischezayushchaya mikrobiota]. Klinicheskaya far-makologiya i terapiya, 23(4), 7-16.
2. GoloshchapovOV, VavilovVN, ZubarovskayaLS, Ka-zantsevIV, VasilyevaYG , KlementyevaRV, AlyanskiyAL, BaikovVV, PainaOV, SemyonovaEV, AfanasyevBV (2011). Fecal calprotectin - a new quantitative biomarker of acute and chronic reaction “graft versus host” with the involvement of the intestine after allogeneic hematopoi-etic stem cell transplantation [Fekal’nyy kal’protektin - novyy kolichestvennyy biomarker ostroy i khronicheskoy reaktsii «transplantat protiv khozyaina» s vovlecheniem kishechnika posle allogennoy transplantatsii gemopoet-icheskikh stvolovykh kletok]. Klinicheskaya onkogema-tologiya, 4(1), 3-7.
3. DolgikhTI (2013). Fecal calprotectin - a non-invasive biomarkers of inflammation in the intestines [Fekal’nyy kal’protektin - neinvazivnyy biomarker vospalitel’nogo protsessa v kishechnike]. Laboratoriya. Spetsvypusk, (2), 44-6.
4. KashtanovaDA, TkachevaON, BoytsovSA (2015). In-testinal microbiota and the factors of cardiovascular risk. Part 1 Intestinal microbiota, age and gender [Mikrobiota kishechnika i faktory kardiovaskulyarnogo riska. Chast’ 1. Mikrobiota kishechnika, vozrast i pol]. Kardiovaskulyar-naya terapiya i profilaktika, 14 (4), 92-95.
5. KashtanovaDA, TkachevaON, BoytsovSA (2015). Intestinal microbiota and the factors of cardiovascular risk. Part 2. Intestinal microbiota and obesity [Mikrobiota kishechnika i faktory kardiovaskulyarnogo riska. Chast’ 2. Mikrobiota kishechnika i ozhirenie]. Kardiovaskulyarnaya terapiya i profilaktika. 14 (5), 83-86.
6. KuchumovaSYu, PoluektovaEA, SheptulinAA, Ivash-kinVT (2011). The physiological significance of the intes-tinal microflora [Fiziologicheskoe znachenie kishechnoy mikroflory]. Rossiyskiy zhurnal gastroenterologii, gepa-tologii, koloproktologii. 21 (5), 17-27.
7. MikhaylovaEI, PimanovSI, VoropaevEV, TimashovaVR (2007). The fecal marker of ulcerative colitis [Fekal’nyy marker yazvennogo kolita]. Rossiyskiy zhurnal gastroenter-ologii, gepatologii, koloproktologii. 17 (5), 60-63.
8. PoluektovaEA, LyashenkoOS, KorolevAV, ShifrinOS, IvashkinVT (2014). Mechanisms to ensure the interaction of bacterial cells with the host, and a violation of patients with inflammatory bowel disease patients [Mekhanizmy, obespechivayushchie vzaimodeystvie bakterial’nykh kle-tok s organizmom khozyaina, i ikh narushenie u patsientov s vospalitel’nymi zabolevaniyami kishechnika]. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. 24 (5), 42-53.
9. Tat’yaninaOF, EgorovaMV, TsimbalovaEG (2007). Di-agnosis of inflammatory diseases of the colon in children [Diagnostika vospalitel’nykh zabolevaniy tolstoy kishki u detey]. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii, 17 (5, suppl. 30), 117.
10. Tat’yaninaOF, PotapovAS, NamazovaLS, Tsimba-lovaE G, Kucherenko AG, Lokhmatov MM (2008). New features noninvasive diagnosis of inflammatory bowel disease in children [Novye vozmozhnosti neinvazivnoy diagnostiki vospalitel’nykh zabolevaniy kishechnika u detey]. Pediatricheskaya farmakologiya. 5 (3), 20-24.
11. TkachevaON, KashtanovaDA, BoytsovSA (2015). Intestinal microbiota and the factors of cardiovascular risk. Part3: The lipid profile, carbohydrate metabolism and intestinal microbiota [Mikrobiota kishechnika i faktory kardiovaskulyarnogo riska. Chast’ 3. Lipidnyy profil’, uglevodnyy obmen i mikrobiota kishechnika]. Kardiovaskulyarnaya terapiya i profilaktika. 14 (6), 83-86
12. AagaardK, MaJ, AntonyKM, PetrosinoJ, Versalo-vicJ (2014). The placenta harbors a unique microbiome. Sci. Transl. Med. 6 (237), 237ra65.
13. BergstromA, SkovTH, BahlML, RoagerHM, ChristensenLB, EjlerskovKT, Mølgaard C, Michaelsen KF, Licht TR (2014). Establishment of intestinal microbiota during early life: a longitudinal explorative study of a large cohort of Danish infants. Appl. Environ. Microbiol.80 (9), 2889-2900.
14. CaniPD, BibiloniR, KnaufC, WagetA, Ney-rinckAM, DelzenneNM, Burcelin R (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabe-tes in mice. Diabetes. 57 (6), 1470-1481.
15. CoorevitsL, BaertFJ, VanpouckeHJ (2013). Faecal calprotectin comparative study of the Quantum Blue rapid test and an established ELISA method. Clin. Chem. Lab. Med., 51(4), 825-831.
16. DaleI, BrandtzaegP, FagerholMK, ScottH (1985). Distribution of new myelomonocytic antigen (L1) in hu-man peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Amer. J. Clin. Pathol., 84(1), 24-34.
17. FagerholMK, AnderssonKB, Naess-AndresenCF, Brandtzaeg P, Dale I (1990). Calprotectin (the L1 leucocyte protein). In: Smith VL, Dedman JR., eds. Stimulus response coupling: the role of intracellular calcium-binding proteins, 187-210.
18. GhoshalS, WittaJ, ZhongI, de VilliersW, Eck-hardtE (2009). Chylomicrons promote intestinal absorp-tion of lipopolysaccharides. J. Lipid. Res., 50 (1), 90-97.
19. HaqK, McElhaneyJE (2014). Immunosenescence: Influenza vaccination and the elderly. Curr. Opin. Immunol., 29, 38-42.
20. KrishnanS, RamakrishnaBS, BinderHJ (1999). Stimulation of sodium chloride absorption from secreting rat colon by shot-chain fatty acids. Dig. Dis. Sci.,44 (9), 1924-1930.
21. RoedigerWE, DuncanA, KapanirisO, MillardS (1993). Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology, 104 (3), 802-809.
22. SchwartzM, RegueiroM (2011). Prevention and treatment of postoperative Crohn’s disease recurrence: an update for a new decade. Curr. Gastroenterol. Rep., 13(1), 95-100.
23. ShenTY, QinHL, GaoZG, FanXB, HangXM, JiangYQ (2006). Influences of enteral nutrition combined with probiotics on gut microflora and barrier function of rats with abdominal infection. World. J. Gastroenterol., 12(27), 4352-4358.
24. SudanD, VargasL, SunY, BokL, DijkstraG, Lan-gnasA (2007). Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. Ann. Surg., 246 (2), 311-315.
25. SuzukiT, YoshidaS, HaraH (2008). Physiologi-cal concentration of short-chain fatty acids immediately suppress colonic epithelial permeability. Br. J. Nutr., 100(2), 297-305.
26. TiihonenK, TynkkynenS, OuwehandA, AhlroosT, RautonenN (2008). The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointesti-nal microbiology and immunology. Br. J. Nutr., 100 (1), 130-137.
